MedTrace Logo

Efficacy of the ATP Switch Automatic Programming in Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D) Implanted Patients

NCT01169246 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1254

Last updated 2019-03-25

No results posted yet for this study

Summary

Primary objective is to assess the efficacy of the new ATP Autoswitch function in simple, dual or triple chamber ICD.

Conditions

  • Ventricular Arrythmias

Sponsors & Collaborators

  • Sorin Group France SAS

    collaborator UNKNOWN

  • MicroPort CRM

    lead INDUSTRY

Principal Investigators

  • SAVOURE Arnaud, MD · CHU Rouen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01169246 on ClinicalTrials.gov